Women in Clinical Trials: Resources for Researchers and Health Professionals
From the FDA Office of Women's Health
On this page: Diverse Women in Clinical Trials Campaign | Why it’s important | Resources | Related links
Diverse Women in Clinical Trials Campaign
The FDA Office of Women’s Health (OWH) is partnering with the National Institutes of Health (NIH) Office of Research on Women’s Health to raise awareness about clinical trial participation by women of all ages, races, and ethnicities, various chronic health conditions and disabilities, as well as those who are pregnant and lactating. The initiative also works to share best practices about clinical research design, recruitment, and demographic analyses.
Learn more about FDA OWH Women in Clinical Trials: Research and Policy.
FDA OWH collaborates with a variety of public and private stakeholders to conduct educational outreach, host scientific workshops and webinars, and promote resources for investigators. Sign up for our mailing list for the latest, including new women’s health information and campaign materials as they become available.
Why it’s important
There are important differences between men and women that can affect health, disease, and response to treatment. Today, women of all ages, races, and ethnicities, irrespective of pregnancy or breastfeeding status, and women with disabilities or chronic health conditions volunteer to participate in clinical trials. Women who participate in clinical trials can help to improve the health of all women.
Resources
- Diverse Women in Clinical Trials Campaign Partner Toolkit
- Use our Partner Toolkit to inform the women in your network about clinical trials. The toolkit includes resources for 'everyday' women and health professionals including fact sheets, sample social media and email messages, and articles.
-
Download our Diverse Women in Clinical Trials fact sheet in English or Spanish.
- Bringing Clinical Research to Patients Webinar
- OWH, in collaboration with FDA Center for Drug Evaluation and Research (CDER) Office of Medical Policy (OMP), hosted a free public webinar to discuss the new strategies currently available for bringing clinical research to all patients, including women.
- Watch recording. CME/CNE/CPE available until January 24, 2027 (1 hour)
- OWH, in collaboration with FDA Center for Drug Evaluation and Research (CDER) Office of Medical Policy (OMP), hosted a free public webinar to discuss the new strategies currently available for bringing clinical research to all patients, including women.
Additional resources
- Enhance EQUITY Initiative
- FDA’s Office of Minority Health and Health Equity offers research projects and communication resources to help enhance equity and diversity in clinical trials.
- NIH Inclusion Outreach Toolkit
- How to engage, recruit, and retain women in clinical research. The toolkit includes a discussion of NIH policies on inclusion, case studies that highlight effective recruitment practices, and other resources for health professionals and researchers.
Related links
- Basics About Clinical Trials
- Websites with Information About Clinical Trials
- FDA Works to Make Informed Consent Easier to Understand
- Clinical Trial Diversity - information from the FDA Office of Minority Health and Health Equity, including fact sheets, brochures, and infographics in several languages, and a variety of videos.
- Clinical trials and studies - Resources from NIH National Institute on Aging.
- NIH Office of Research on Women's Health Video Playlist (YouTube)
- NIH Videos - Personal Stories from Women who Participated in a Clinical Trial